• Study Cancellations Undercut Site Viability, Stakeholders Say

    Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution.

    Aug 28, 2025

  • Follow the Money: Supplying Global Clinical Trials, Novel Next-Gen Biosensor, More

    Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more.

    Aug 27, 2025

  • International Progressive MS Alliance Launches Data Platform, N-Power Launches Novel Platform, More

    Clinical Research News | The International Progressive MS Alliance launched its MS Clinical and Imaging Data Resource (CIDR); N-Power Medicine announced the launch of the industry’s first Prospective External Control Arm (ProECA) platform; and more.

    Aug 26, 2025

  • Navigating the Complexities of Radiopharmaceutical Therapy Trials

    Clinical Research News | Radiopharmaceutical therapy (RPT) has been around for a long time now, but advances in technology and understanding of the actionable molecular pathways that drive cancer have fueled a resurgence in interest and investment in the therapeutic modality. he popularity of RPTs is driven largely by theranostics combining diagnostic imaging and targeted therapy into a single, integrated system to more precisely deliver radiation to tumor cells and thereby minimize damage to healthy tissue.

    Aug 21, 2025

  • Non-Invasive Medical Devices Show Clinical Promise Across Multiple Indications

    Clinical Research News | Clinical trials and preclinical studies are demonstrating the therapeutic potential of Openwater's infrared light and low-intensity focused ultrasound technologies across a diverse range of medical conditions, from cancer treatment to stroke diagnosis.

    Aug 19, 2025

  • Latin America the ‘Hidden Gem’ for First-in-Human Medical Device Trials

    Clinical Research News | The big holdup in the development of advanced medical devices seems inevitably to happen at the point where first-in-human clinical trials are to begin, at least if the studies are to be conducted in the U.S. where it can be difficult to find clinical leaders, recruit patients, and bear the overall financial burden of their execution.

    Aug 14, 2025

  • Regulatory Proposals Good Match to Priorities of New FDA

    Clinical Research News | Regardless of how one views the priorities of the Food and Drug Administration (FDA) under the new administration, it’s an opportunity for badly needed change to “shake things up,” according to Doug Bain, founder and consulting partner of UK-based ClinFlo, a newly launched consulting and service company focused on the application of technology to improve clinical research.

    Aug 13, 2025